Shuting Li
Impact in
- Pollution top 5%
- Wastewater Treatment and Nitrogen Removal
- Pharmaceutical and Antibiotic Environmental Impacts
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
-
- Wound Healing and Treatments 8
-
- Dialysis and Renal Disease Management 6
- Co-authors
- Jinwan Wang (2 shared papers)Peige Song (22 shared papers)Yihebali Chi (1 shared paper)Hao Yu (1 shared paper)Feng‐Qing Wang (1 shared paper)Wei Niu (1 shared paper)Chunxia Du (1 shared paper)Li Li (1 shared paper)
- Journals
- Journal of Global Health (4 papers)Frontiers in Endocrinology (3 papers)Frontiers in Public Health (3 papers)PLoS ONE (2 papers)International Journal of Biological Macromolecules (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Shuting Li
112 papers receiving 2.2k citations
Shuting Li's Hit Papers
Peers
Comparison fields: 5 of 142
- Pollution 192
- Rehabilitation 104
- Nephrology 112
- Structural Biology 25
- Endocrinology, Diabetes and Metabolism 158
Countries citing papers authored by Shuting Li
This map shows the geographic impact of Shuting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Li more than expected).
Fields of papers citing papers by Shuting Li
This network shows the impact of papers produced by Shuting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Li. The network helps show where Shuting Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuting Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors Hit paper breakdown → | 2016 | 357 |
| 2 | 2021 | 125 | |
| 3 | 2020 | 86 | |
| 4 | 2017 | 85 | |
| 5 | 2024 | 64 | |
| 6 | 2021 | 52 | |
| 7 | 2022 | 51 | |
| 8 | 2023 | 51 | |
| 9 | 2017 | 45 | |
| 10 | 2022 | 45 | |
| 11 | 2019 | 44 | |
| 12 | 2019 | 43 | |
| 13 | 2020 | 39 | |
| 14 | 2021 | 39 | |
| 15 | 2022 | 36 | |
| 16 | 2022 | 35 | |
| 17 | 2022 | 34 | |
| 18 | 2020 | 33 | |
| 19 | 2023 | 33 | |
| 20 | 2016 | 30 |
About Shuting Li
Shuting Li is a scholar working on Rehabilitation, Nephrology, Endocrinology, Diabetes and Metabolism, Health, Toxicology and Mutagenesis and Nutrition and Dietetics, having authored 121 papers that have together received 2.3k indexed citations. Recurring topics across this work include Wound Healing and Treatments (8 papers), Dialysis and Renal Disease Management (6 papers), Retinal Diseases and Treatments (5 papers), Air Quality and Health Impacts (5 papers), Glioma Diagnosis and Treatment (4 papers), Crystallization and Solubility Studies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Pollution (192 citations), Rehabilitation (104 citations), Nephrology (112 citations), Structural Biology (25 citations) and Endocrinology, Diabetes and Metabolism (158 citations). Shuting Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jinwan Wang, Peige Song, Yihebali Chi, Hao Yu, Feng‐Qing Wang, Wei Niu, Chunxia Du, Li Li, Chuan Li and Yongkun Sun. Their work appears in journals such as Journal of Global Health, Frontiers in Endocrinology, Frontiers in Public Health, PLoS ONE and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.